Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.88
+0.13 (0.75%)
At close: Sep 11, 2026, 4:00 PM EDT
16.85
-0.02 (-0.15%)
After-hours: Sep 11, 2026, 7:30 PM EDT

Rallybio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
90294090249307
Market Cap Growth
257.43%-27.23%-55.91%-63.67%-18.90%-
Enterprise Value
-3-30-35-31117120
Last Close Price
16.885.497.6819.1252.5676.32

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
138.7233.7862.62---
PB Ratio
0.950.500.650.851.471.75
P/TBV Ratio
0.950.500.650.851.471.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.000.000.00-
Net Debt / Equity Ratio
-0.98-0.94-1.06-1.03-0.99-1.00
Net Debt / EBITDA Ratio
3.661.751.151.392.493.85
Net Debt / FCF Ratio
-3.481.831.331.822.943.82
Asset Turnover
0.010.010.01---
Quick Ratio
26.0312.9610.5011.8715.7326.76
Current Ratio
27.2714.5110.8712.3916.7127.61
Return on Equity (ROE)
64.86%-15.01%-68.85%-54.13%-38.65%-30.18%
Return on Assets (ROA)
-21.32%-30.07%-38.91%-33.33%-23.40%-17.61%
Return on Capital Employed (ROCE)
-26.90%-54.00%-92.50%-74.20%-40.00%-26.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
50.83%-30.98%-145.06%-82.55%-26.81%-15.34%
FCF Yield
29.81%-102.86%-123.74%-66.73%-23.06%-14.96%
Buyback Yield / Dilution
-2.02%-3.42%-7.66%-27.11%-24.70%-46.76%
SEC Filings: 10-K · 10-Q